FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 308:1396-1399 June 9, 1983 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Idiopathic thrombocytopenic purpura is an autoimmune disorder, most common in young women. We treated 22 patients with this disorder (12 of whom were women) with danazol, an androgen with reduced virilizing capability, for two months or longer. Fifteen had undergone splenectomy, all were receiving glucocorticoids, and 18 had also been given other treatments. Fifteen of the patients were benefited, 11 with sustained normalization of their platelet counts. Six of eight patients tested had initial increases in circulating platelet-reactive IgG; in all six there was a marked decrease concomitant with danazol therapy. Danazol was effective in both men and women, irrespective of previous treatments. The duration of remissions ranged from 2 to 13 months. The drug was well tolerated and appears to be better suited than glucocorticoids for long-term management of idiopathic thrombocytopenic purpura, but the exact indications for the use of danazol in this disorder remain to be determined.

This article has been cited by other articles:

• Vesely, S. K., Perdue, J. J., Rizvi, M. A., Terrell, D. R., George, J. N. (2004). Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review. ANN INTERN MED 140: 112-120 [Abstract] [Full Text]  
• Nomura, S., Matsuzaki, T., Ozaki, Y., Yamaoka, M., Yoshimura, C., Katsura, K., Xie, G. L., Kagawa, H., Ishida, T., Fukuhara, S. (1998). Clinical Significance of HLA-DRB1*0410 in Japanese Patients With Idiopathic Thrombocytopenic Purpura. Blood 91: 3616-3622 [Abstract] [Full Text]  
• Kim, S. W., Rice, L., McCarthy, J. J. (1997). Efficacy of Danazol with Autoimmune Thrombocytopenia. CLIN APPL THROMB HEMOST 3: 251-255 [Abstract]  
• Sakuragawa, N., Yasunaga, K., Nomura, T., Akatsuka, J., Kuramoto, A., Matsuda, J., Nomura, S. (1996). Clinical Study of TJ-137 Tsumura Kami-kihi-to in Patients with Idiopathic Thrombocytopenic Purpura (ITP). CLIN APPL THROMB HEMOST 2: 213-218 [Abstract]  
• Wittels, E. G., Siegel, R. D., Mazur, E. M. (1990). Thrombocytopenia in the Intensive Care Unit Setting. J Intensive Care Med 5: 224-240 [Abstract]  
• Ahn, Y. S., Rocha, R., Mylvaganam, R., Garcia, R., Duncan, R., Harrington, W. J. (1989). Long-Term Danazol Therapy in Autoimmune Thrombocytopenia: Unmaintained Remission and Age-Dependent Response in Women. ANN INTERN MED 111: 723-729 [Abstract]  
• Ravikumar, T. S., Allen, J. D., Bothe, A. Jr, Steele, G. Jr (1989). Splenectomy: The Treatment of Choice for Human Immunodeficiency Virus-Related Immune Thrombocytopenia?. Arch Surg 124: 625-628 [Abstract]  
• Weinblatt, M. E., Kochen, J., Ortega, J. (1988). Danazol for Children With Immune Thrombocytopenic Purpura. Arch Pediatr Adolesc Med 142: 1317-1319 [Abstract]  
• Gately, L. E. III, Andes, W. A. (1988). Danazol and Erythema Multiforme. ANN INTERN MED 109: 85-85 [Abstract]  
• WEST, S. G., JOHNSON, S. C. (1988). Danazol for the Treatment of Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus. ANN INTERN MED 108: 703-706 [Abstract]  
• AHN, Y. S., MYLVAGANAM, R., GARCIA, R. O., KIM, C. I., PALOW, D., HARRINGTON, W. J. (1987). Low-Dose Danazol Therapy in Idiopathic Thrombocytopenic Purpura. ANN INTERN MED 107: 177-181 [Abstract]  
• FRANCOIS, B., COFFIN, B., DELFRAISSY, J.-F. (1986). Danazol and Cholestatic Hepatitis. ANN INTERN MED 105: 139-140 [Abstract]  
• ROSENFELT, F. P., ROSENBLOOM, B. E., WEINSTEIN, I. M. (1986). Immune Thrombocytopenia in Homosexual Men. ANN INTERN MED 104: 583-584 [Abstract]  
• Marino, C., Cook, P. (1985). Danazol for Lupus Thrombocytopenia. Arch Intern Med 145: 2251-2252 [Abstract]  
• CINES, D. B., CASSILETH, P. A, KISS, J. E. (1985). Danazol Therapy in Myelodysplasia. ANN INTERN MED 103: 58-60 [Abstract]  
• AHN, Y. S., HARRINGTON, W. J., MYLVAGANAM, R., AYUB, J., PALL, L. M. (1985). Danazol Therapy for Autoimmune Hemolytic Anemia. ANN INTERN MED 102: 298-301 [Abstract]  
• HALL, S., McCORMICK, J. L. Jr., GREIPP, P. R., MICHET, C. J. Jr., McKENNA, C. H. (1985). Splenectomy Does Not Cure the Thrombocytopenia of Systemic Lupus Erythematosus. ANN INTERN MED 102: 325-328 [Abstract]  
• Gralnick, H. R., Maisonneuve, P., Sultan, Y., Rick, M. E. (1985). Benefits of Danazol Treatment in Patients With Hemophilia A (Classic Hemophilia). JAMA 253: 1151-1153 [Abstract]  
• Garewal, H. S., Corrigan, J. J. Jr, Durie, B. G. M., Jeter, M. A., Damiano, M. L. (1985). Effect of Danazol on Coagulation Parameters and Bleeding in Hemophilia. JAMA 253: 1154-1156 [Abstract]  
• Grossman, C. (1985). Interactions between the gonadal steroids and the immune system. Science 227: 257-261 [Abstract]  
• Strother, S. V., Zuckerman, K. S., LoBuglio, A. F. (1984). Colchicine Therapy for Refractory Idiopathic Thrombocytopenic Purpura. Arch Intern Med 144: 2198-2200 [Abstract]  
• METROKA, C. E., MOORE, A., SONNABEND, J. A., CUNNINGHAM-RUNDLES, S. (1984). Risks with Danazol in the Acquired Immunodeficiency Syndrome. ANN INTERN MED 101: 564-565 [Abstract]  
• PILLAI, M. V., SPENCER, C. D., SONODA, T. (1984). Vinca Alkaloids for Idiopathic Thrombocytopenic Purpura. ANN INTERN MED 101: 149-150 [Abstract]  
• AHN, Y. S., HARRINGTON, W. J., MYLVAGANAM, R., ALLEN, L. M., PALL, L. M. (1984). Slow Infusion of Vinca Alkaloids in the Treatment of Idiopathic Thrombocytopenic Purpura. ANN INTERN MED 100: 192-196 [Abstract]